UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus‐related cancer incidence by gender and anatomic site of infection

International journal of cancer, 2015-06, Vol.136 (12), p.2752-2760

2015

Volltextzugriff (PDF)

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

Cancer epidemiology, biomarkers & prevention, 2014-10, Vol.23 (10), p.1997-2008

2014

Volltextzugriff (PDF)

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

The Lancet (British edition), 2009-06, Vol.373 (9679), p.1949-1957

2009

Volltextzugriff (PDF)

Traité des infections et pathologies génitales à papillomavirus

Monsonego, Joseph

1. Aufl., 2007

Volltextzugriff (PDF)

Genital infection with HPV in men: research into practice

The Lancet (British edition), 2011-03, Vol.377 (9769), p.881-883

Monsonego, Joseph

2011

Volltextzugriff (PDF)

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice

International journal of cancer, 2017-05, Vol.140 (10), p.2192-2200

2017

Volltextzugriff (PDF)

Response to Letter to the Editor by Tsu et al. “Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine”

Vaccine, 2011-11, Vol.29 (50), p.9292-9293

Monsonego, Joseph

2011

Volltextzugriff (PDF)

Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries

BMC women's health, 2011-05, Vol.11 (1), p.18-18, Article 18

2011

Volltextzugriff (PDF)

Male circumcision for prevention of oncogenic HPV infection – Author's reply

The Lancet (British edition), 2011, Vol.378 (9788), p.315-315

Monsonego, Joseph

2011

Volltextzugriff (PDF)

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial

Gynecologic oncology, 2015-04, Vol.137 (1), p.47-54

2015

Volltextzugriff (PDF)

HPV testing in prevention of cervical cancer: practices and current trends

Annales de biologie clinique (Paris), 2013-11, Vol.71, p.27-32

Monsonego, Joseph

2013

Volltextzugriff (PDF)

HPV testing in prevention of cervical cancer: practices and current trends

Annales de biologie clinique (Paris), 2013-11, Vol.71 (S1), p.27-32

Monsonego, Joseph

2013

Volltextzugriff (PDF)

The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy

International journal of cancer, 2013-01, Vol.132 (1), p.101-108

2013

Volltextzugriff (PDF)

Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review

Oral oncology, 2017-04, Vol.67, p.138-145

2017

Volltextzugriff (PDF)

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease

International journal of cancer, 2012-11, Vol.131 (9), p.1969-1982

2012

Volltextzugriff (PDF)

Test HPV et prévention du cancer du col utérin: pratiques et tendances actuelles: Prospective en biologie médicale et biomarqueurs innovants

Annales de biologie clinique (Paris), 2013, Vol.71 (NOV), p.27-32

MONSONEGO, Joseph

2013

Volltextzugriff (PDF)

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid‐based cytology in primary cervical cancer screening: The FASE study

International journal of cancer, 2011-08, Vol.129 (3), p.691-701

2011

Volltextzugriff (PDF)

Turning the tide—Recommendations to increase cervical cancer screening among women who are underscreened

International journal of gynecology and obstetrics, 2024-06, Vol.166, p.3-21

2024

Volltextzugriff (PDF)

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

Journal of clinical virology, 2009-07, Vol.45, p.S55-S61

2009

Volltextzugriff (PDF)

EUROGIN 2006 expert consensus report: Innovations in cervical cancer prevention: Science, practice and actions

Gynecologic oncology, 2006-10, Vol.103 (1), p.7-7

Monsonego, Joseph

2006

Volltextzugriff (PDF)

EUROGIN 2006 expert consensus report

Gynecologic oncology, 2006-10, Vol.103 (1), p.7

Monsonego, Joseph

2006

Volltextzugriff (PDF)

Eurogin 2010 roadmap on cervical cancer prevention

International journal of cancer, 2011-06, Vol.128 (12), p.2765-2774

2011

Volltextzugriff (PDF)

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice: Eurogin 2016 Roadmap

International journal of cancer, 2017-05, Vol.140 (10), p.2192-2200

2017

Volltextzugriff (PDF)

Infections à papillomavirus: État des connaissances, pratiques et prévention vaccinale

Monsonego, Joseph

1. Aufl., 2006

Volltextzugriff (PDF)

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study)

Gynecologic oncology, 2012-04, Vol.125 (1), p.175-180

2012

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(65)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus‐related cancer incidence by gender and anatomic site of infection

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

Traité des infections et pathologies génitales à papillomavirus

Genital infection with HPV in men: research into practice

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice

Response to Letter to the Editor by Tsu et al. “Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine”

Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries

Male circumcision for prevention of oncogenic HPV infection – Author's reply

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial

HPV testing in prevention of cervical cancer: practices and current trends

HPV testing in prevention of cervical cancer: practices and current trends

The APTIMA HPV assay versus the hybrid capture 2 test in triage of women with ASC‐US or LSIL cervical cytology: A meta‐analysis of the diagnostic accuracy

Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease

Test HPV et prévention du cancer du col utérin: pratiques et tendances actuelles: Prospective en biologie médicale et biomarqueurs innovants

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid‐based cytology in primary cervical cancer screening: The FASE study

Turning the tide—Recommendations to increase cervical cancer screening among women who are underscreened

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

EUROGIN 2006 expert consensus report: Innovations in cervical cancer prevention: Science, practice and actions

EUROGIN 2006 expert consensus report

Eurogin 2010 roadmap on cervical cancer prevention

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice: Eurogin 2016 Roadmap

Infections à papillomavirus: État des connaissances, pratiques et prévention vaccinale

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study)

Suchergebnisse filtern